ArticleFrontiers in immunology2023

Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot study.

Guangming Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.